The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Abstract
Drugs of abuse are very powerful reinforcers, and even in conditions of limited access (where the organism is not dependent) these drugs will motivate high rates of operant responding. This presumed hedonic property and the drugs' neuropharmacological specificity provide a means of studying the neuropharmacology and neuroanatomy of brain reward. Three major brain systems appear to be involved in drug reward--dopamine, opioid and GABA. Evidence suggests a midbrain-forebrain-extrapyramidal circuit with its focus in the nucleus accumbens. Data implicating dopamine and opioid systems in indirect sympathomimetic and opiate reward include critical elements in both the nucleus accumbens and ventral tegmental areas. Ethanol reward appears to depend on an interaction with the GABAA receptor complex but may also involve common elements such as dopamine and opioid peptides in this midbrain-forebrain-extrapyramidal circuit. These results suggest that brain reward systems have a multidetermined neuropharmacological basis that may involve some common neuroanatomical elements.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, there is extensive experimental evidence in animal contexts supporting a role for the mesolimbic reward pathway on appetitive and motivational behaviors [306,307].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [307]
In the citing paper
“The meso-limbic dopamine system that projects from the ventral tegmental area (VTA) to the nucleus accumbens has been implicated in the rewarding effects of drugs of abuse”
From Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens–olfactory tubercle complex (2007) · cites this paper as Koob, 1992
Citations
Cites
Handbook of Psychopharmacology
Iversen, L. L., Iversen, S. D., & Snyder, S. H. (1988) · Springer eBooks · doi:10.1007/978-1-4613-0933-8 · Cited by 2,756
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
From motivation to action: Functional interface between the limbic system and the motor system
MOGENSON, G., JONES, D., & YIM, C. (1980) · Progress in Neurobiology · doi:10.1016/0301-0082(80)90018-0 · Cited by 2,331
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Self-citationWise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968
An opponent-process theory of motivation. I. Temporal dynamics of affect
Solomon, R. L., & Corbit, J. D. (1974) · Psychological Review · doi:10.1037/h0036128 · Cited by 1,704
Alheid, G. F., & Heimer, L. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90217-5 · Cited by 1,217
Fallon, J. H., & Moore, R. Y. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901800310 · Cited by 1,190
Mesocorticolimbic dopaminergic network: functional and regulatory roles
Moal, M. L., & Simon, H. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.1.155 · Cited by 1,108
Di Chiara, G., & Imperato, A. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24578-5 · Cited by 916
Research works printed but not linked: 21
- Dahlström, 1964, Acta Physiol. Scand., 232, 1
- Weiss, F. et al.Ann. NY Acad. Sci. (in press).
- Pfeffer, 1985, Alcohol Drug Res., 6, 37
- Rassnick, S., Pulvirenti, L. and Koob, G. F. Psychopharmacology (in press).
- Samson, 1988, Alcohol. Clin. Exp. Res., 12, 581
- Imperato, 1986, J. Pharmacol. Exp. Ther., 239, 221
- Bodnar, 1990, Crit. Rev. Neurobiol., 6, 39
- West, 1989, Soc. Neurosri. Abstr., 15, 20.8
- Koob, 1984, J. Pharmacol. Exp. Ther., 229, 481
- Goldberg, 1971, J. Pharmacol. Exp. Ther., 176, 464
- Di Chiara, 1988, J. Pharmacol. Exp. Ther., 244, 1067
- Di Chiara, 1988, 85, 5274
- Shippenberg, T. S., Spanagel, R. and Herz, A.Ann. NY Acad. Sci. (in press).
- Givens, 1990, J. Pharmacol. Exp. Ther., 254, 528
- Sepinwall, 1978, Vol. 13, 345
- Koob, G. F. and Britton, K. T. in Pharmacology and Neuropharmacology (Vol. 2) Alcohol and Alcoholisms (Begleiter, H. and Kissin, B., eds), Oxford University Press (in press).
- Frye, 1982, J. Pharmacol. Exp. Ther., 223, 750
- Suzdak, 1986, 83, 4071
- Rassnick, S. et al.Ann. NY Acad. Sci. (in press).
- Deitrich, 1989, Pharmacol. Rev., 41, 489
- Pickens, 1981, J. Pharmacol. Exp. Ther., 216, 205
Cited by
Sorted by citations
Items 201–300 of 1,004
Functional brain imaging of tobacco use and dependence
BRODY, A. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.04.012 · Cited by 207
Schilström, B., Svensson, H. M., Svensson, T. H., & Nomikos, G. G. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00114-6 · Cited by 207
Sensitization of Midbrain Dopamine Neuron Reactivity Promotes the Pursuit of Amphetamine
Vezina, P., Lorrain, D. S., Arnold, G. M., Austin, J. D., & Suto, N. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04654.2002 · Cited by 206
Shadel, W. G., Shiffman, S. M., NIAURA, R. S., Nichter, M., & Abrams, D. B. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00162-3 · Cited by 203
Whole-Cell Plasticity in Cocaine Withdrawal: Reduced Sodium Currents in Nucleus Accumbens Neurons
Zhang, X.-F., Hu, X., & White, F. J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00488.1998 · Cited by 203
Sugars as tobacco ingredient: Effects on mainstream smoke composition
Talhout, R., Opperhuizen, A., & van Amsterdam, J. (2006) · Food and Chemical Toxicology · doi:10.1016/j.fct.2006.06.016 · Cited by 202
Neurochemical Bases of Locomotion and Ethanol Stimulant Effects
Phillips, T. J., & Shent, E. H. (1996) · International review of neurobiology · doi:10.1016/s0074-7742(08)60669-8 · Cited by 202
Dumais, K. M., Bredewold, R., Mayer, T. E., & Veenema, A. H. (2013) · Hormones and Behavior · doi:10.1016/j.yhbeh.2013.08.012 · Cited by 201
Fadda, P., Scherma, M., Fresu, A., Collu, M., & Fratta, W. (2003) · Synapse · doi:10.1002/syn.10238 · Cited by 200
Vries, T. J. D. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00293-7 · Cited by 200
Tanda, G., & Chiara, G. D. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00135.x · Cited by 200
Drugs of abuse and immediate-early genes in the forebrain
Harlan, R. E., & Garcia, M. M. (1998) · Molecular Neurobiology · doi:10.1007/bf02741385 · Cited by 199
α-Conotoxin MII Blocks Nicotine-Stimulated Dopamine Release in Rat Striatal Synaptosomes
Kulak, J. M., Nguyen, T. A., Olivera, B. M., & McIntosh, J. M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05263.1997 · Cited by 198
Harvey, J., & Lacey, M. G. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05271.1997 · Cited by 198
Adell, A., & Artigas, F. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.05.001 · Cited by 197
Ploj, K., Roman, E., & Nylander, I. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00499-8 · Cited by 197
Beitner‐Johnson, D., Guitart, X., & Nestler, E. J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb09814.x · Cited by 197
Basile, A. S., Fedorova, I. D., Zapata, A. G., Liu, X., Shippenberg, T. S., Duttaroy, A., Yamada, M., & Wess, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162371899 · Cited by 195
Neurobiochemical and clinical aspects of craving in alcohol addiction: A review
Addolorato, G., Leggio, L., Abenavoli, L., & Gasbarrini, A. (2005) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.12.011 · Cited by 194
WALSH, S. L., & Cunningham, K. A. (1997) · Psychopharmacology · doi:10.1007/s002130050210 · Cited by 194
Dopamine and alcoholism: neurobiological basis of ethanol abuse
Tupala, E., & Tiihonen, J. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.06.022 · Cited by 193
D2 dopamine receptor gene and obesity
Noble, E. P., Noble, R. E., Ritchie, T. L., Syndulko, K., Bohlman, M. C., Noble, L. A., Zhang, Y. A., Sparkes, R. S., & Grandy, D. K. (1994) · International Journal of Eating Disorders · doi:10.1002/1098-108x(199404)15:3 · Cited by 193
Gianoulakis, C. (2001) · PubMed Central · Cited by 193
Chronic Opioid Treatment Induces Adenylyl Cyclase V Superactivation
Avidor‐Reiss, T., Nevo, I., Levy, R., Pfeuffer, T., & Vogel, Z. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.21309 · Cited by 193
Understanding endorphins and their importance in pain management.
Sprouse‐Blum, A. S., Smith, G., Sugai, D. Y., & Parsa, F. D. (2010) · Europe PMC (PubMed Central) · Cited by 192
Reith, M. E. A., Li, M.-Y., & Yan, Q. (1997) · Psychopharmacology · doi:10.1007/s002130050454 · Cited by 192
Regulations of opioid dependence by opioid receptor types
Narita, M., Funada, M., & Suzuki, T. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00099-1 · Cited by 191
Baclofen Attenuates the Reinforcing Effects of Cocaine in Rats
Roberts, D. C. S. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(96)00002-4 · Cited by 190
Using Knockout and Transgenic Mice to Study Neurophysiology and Behavior
Picciotto, M. R., & Wickman, K. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.4.1131 · Cited by 189
The central GLP-1: implications for food and drug reward
Skibicka, K. P. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00181 · Cited by 188
Ericson, M., Blomqvist, O., Engel, J. A., & Söderpalm, B. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00602-5 · Cited by 188
Rebec, G. V., Grabner, C. P., Johnson, M., Pierce, R. C., & Bardo, M. T. (1996) · Neuroscience · doi:10.1016/s0306-4522(96)00382-x · Cited by 187
Genetic factors influencing alcohol dependence
Mayfield, R. D., Harris, R. A., & Schuckit, M. A. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.88 · Cited by 186
Cadoni, C., & Chiara, G. D. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00466-7 · Cited by 186
Molecular Mechanisms Underlying Behaviors Related to Nicotine AddictionPreprint
Picciotto, M. R., & Kenny, P. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012112 · Cited by 186
Food Restriction Enhances the Central Rewarding Effect of Abused Drugs
de Vaca, S. C., & Carr, K. D. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-18-07502.1998 · Cited by 185
Hodge, C. W., Samson, H. H., & Chappelle, A. M. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1997.tb04257.x · Cited by 185
Nicola, S. M., & Malenka, R. C. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05697.1997 · Cited by 185
Lack of Self-Administration of Cocaine in Dopamine D 1 Receptor Knock-Out Mice
Caine, S. B., Thomsen, M., Gabriel, K. I., Berkowitz, J. S., Gold, L. H., Koob, G. F., Tonegawa, S., Zhang, J., & Xu, M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2284-07.2007 · Cited by 183
Self-citationVentral Striatal Dopamine Release in Response to Smoking a Regular vs a Denicotinized Cigarette
Brody, A. L., Mandelkern, M. A., Olmstead, R. E., Allen-Martinez, Z., Scheibal, D., Abrams, A. L., Costello, M. R., Farahi, J., Saxena, S., Monterosso, J., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.87 · Cited by 183
Carelli, R. M., & Deadwyler, S. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-12-07735.1994 · Cited by 181
Noble, E. P. (1998) · Alcohol · doi:10.1016/s0741-8329(97)00175-4 · Cited by 180
Association of the κ-opioid system with alcohol dependence
Xuei, X., Dick, D. M., Wetherill, L. F., Tian, H.-J., Arpana Agrawal, A., Bierut, L. J., Goate, A., Bucholz, K. K., Schuckit, M. A., Nürnberger, J. I., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001882 · Cited by 179
Valjent, E., Pagès, C., Rogard, M., Besson, M., Maldonado, R. J., & Caboche, J. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01652.x · Cited by 179
Inhibition of Fear by Learned Safety Signals: A Mini-Symposium Review
Christianson, J. P., Fernando, A. B. P., Kazama, A. M., Jovanović, T., Ostroff, L. E., & Sangha, S. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3340-12.2012 · Cited by 179
Effects of prenatal cigarette and marijuana exposure on drug use among offspring
Porath, A. J., & Fried, P. A. (2005) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2004.12.003 · Cited by 178
Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor A1 allele
Lawford, B. R., Young, R. M., Rowell, J., Qualichefski, J., Fletcher, B. H., Syndulko, K., Ritchie, T. L., & Noble, E. P. (1995) · Nature Medicine · doi:10.1038/nm0495-337 · Cited by 178
Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences
Foll, B. L., & Goldberg, S. R. (2004) · Neuroreport · doi:10.1097/00001756-200409150-00028 · Cited by 178
Antibacterial activity of Brazilian propolis and fractions against oral anaerobic bacteria
Santos, F. A., Bastos, E. M. A. F., de Uzeda, M., Carvalho, M. A. R., Farias, L. M., Moreira, E. S. A., & Braga, F. C. (2002) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(02)00003-x · Cited by 176
Eisch, A. J., & Harburg, G. C. (2006) · Hippocampus · doi:10.1002/hipo.20161 · Cited by 176
White, S. R. (1996) · Progress in Neurobiology · doi:10.1016/0301-0082(96)00027-5 · Cited by 176
Maisonneuve, I. M., Archer, S., & Glick, S. D. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90559-2 · Cited by 176
Abolition of morphine-immunosuppression in mice lacking the μ-opioid receptor gene
Gavériaux‐Ruff, C., Matthes, H. W. D., Peluso, J., & Kieffer, B. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6326 · Cited by 175
The COMBINE Study Research Group (2003) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2003.tb02873.x · Cited by 174
Biochemical Adaptations in the Mesolimbic Dopamine System in Response to Repeated Stress
Ortiz, J. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00152-4 · Cited by 174
Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies
DIMATTEO, V., Giovanni, G. D., Pierucci, M., & Esposito, E. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00902-3 · Cited by 175
Cass, W. A., Zahniser, N. R., Flach, K. A., & Gerhardt, G. A. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb07469.x · Cited by 173
Elucidation of the neurobiology of depression: insights from a novel genetic animal model
Yadid, G., Nakash, R., Roth‐Deri, I., Tamar, G., Kinor, N., Gispan, I. H., & Zangen, A. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00018-6 · Cited by 172
Cellular mechanism for anti-analgesic action of agonists of the κ-opioid receptor
Pan, Z. Z., Tershner, S., & Fields, H. L. (1997) · Nature · doi:10.1038/38730 · Cited by 171
Psychostimulant sensitization: differential changes in accumbal shell and core dopamine
Cadoni, C., Solinas, M., & Chiara, G. D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00824-9 · Cited by 171
Deurwaerdère, P. D., & Giovanni, G. D. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.03.004 · Cited by 170
Dual determinants of drug use in humans: reward and impulsivity.
de Wit, H., & Richards, J. B. (2004) · PubMed · Cited by 168
Sensitization Processes in Drug Addiction
Vanderschuren, L. J. M. J., & Pierce, R. C. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_21 · Cited by 169
Daglish, M. R. C., Weinstein, A. M., Malizia, A. L., Wilson, S., Melichar, J., Britten, S., Brewer, C. L., Lingford-Hughes, A. R., Myles, J. S., Grasby, P. M., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1680 · Cited by 168
A neuroendocrine role in cocaine reinforcement
Goeders, N. E. (1997) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00027-9 · Cited by 168
Cross‐species Studies of Sensorimotor Gating of the Startle Reflex
Swerdlow, N. R., BRAFF, D. L., & Geyer, M. A. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09269.x · Cited by 167
Opiate-induced Adenylyl Cyclase Superactivation Is Isozyme-specific
Avidor‐Reiss, T., Nevo, I., Saya, D., Bayewitch, M. L., & Vogel, Z. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.8.5040 · Cited by 166
Berhow, M. T., Russell, D., Terwilliger, R. Z., Beitner‐Johnson, D., Self, D. W., Lindsay, R. M., & Nestler, E. J. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00207-y · Cited by 165
High Levels of Dopamine Activity in the Basal Ganglia of Cigarette Smokers
Salokangas, R. K. R., Vilkman, H., Ilonen, T., Taiminen, T., Bergman, J., Haaparanta, M., Solin, O., Alanen, A., Syvã«¡hti, E., & Hietala, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.632 · Cited by 164
IMPLICATIONS OF ENDOGENOUS OPIOIDS AND DOPAMINE IN ALCOHOLISM: HUMAN AND BASIC SCIENCE STUDIES
Gianoulakis, C. (1996) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a008216 · Cited by 162
Mechanisms of Nicotine Addiction
Picciotto, M. R., & Kenny, P. J. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039610 · Cited by 161
Tzschentke, T., & Schmidt, W. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11662-g · Cited by 161
Curran, H. V., & Monaghan, L. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.96574910.x · Cited by 159
Human pharmacology of the methamphetamine stereoisomers
Mendelson, J. E., Uemura, N., Harris, D. E., NATH, R., FERNANDEZ, E., JACOBIII, P., Everhart, E. T., & JONES, R. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.06.013 · Cited by 158
Treating Substance Abuse Among Patients With Schizophrenia
Bellack, A. S., & DiClemente, C. C. (1999) · Psychiatric Services · doi:10.1176/ps.50.1.75 · Cited by 158
Lammers, C.-H., Díaz, J., Jc, S., & Sokoloff, P. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000754 · Cited by 157
Graybiel, A. M. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93871-t · Cited by 157
Bolaños, C. A., Garmsen, G. M., Clair, M. A., & McDougall, S. A. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00698-x · Cited by 157
Mattson, B. J., Bossert, J. M., Simmons, D. E., Nozaki, N., Nagarkar, D. R., Kreuter, J. D., & Hope, B. T. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03500.x · Cited by 156
Alcohol use disorders and current pharmacological therapies: the role of GABAA receptors
Liang, J., & Olsen, R. W. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.50 · Cited by 156
Ghods-Sharifi, S., & Floresco, S. (2010) · Behavioral Neuroscience · doi:10.1037/a0018932 · Cited by 155
Nicotine self-administration in animals as a dependence model
Corrigall, W. A. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011121 · Cited by 156
Genetical genomic determinants of alcohol consumption in rats and humans
Alcoholism, W. S. O. S. A. T. M. O., Tabakoff, B., Saba, L. M., Printz, M. P., Flodman, P. L., Hodgkinson, C. A., Goldman, D. A., Koob, G. F., Richardson, H. N., Kechris, K. J., et al. (2009) · BMC Biology · doi:10.1186/1741-7007-7-70 · Cited by 154
Self-citationGlutamatergic transmission in drug reward: implications for drug addiction
D’Souza, M. S. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00404 · Cited by 154
G protein-coupled receptor kinases as regulators of dopamine receptor functions
Gurevich, E. V., Gainetdinov, R. R., & Gurevich, V. V. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.05.010 · Cited by 153
Chang, J.-Y., Janak, P. H., & Woodward, D. J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-08-03098.1998 · Cited by 152
Food Deprivation Decreases mRNA and Activity of the Rat Dopamine Transporter
Patterson, T. A., Brot, M. D., Zavosh, A., Schenk, J. O., Szot, P., & Figlewicz, D. P. (1998) · Neuroendocrinology · doi:10.1159/000054345 · Cited by 152
Sigma1 (σ1) receptor antagonists represent a new strategy against cocaine addiction and toxicity
Maurice, T., Martin‐Fardon, R., Romieu, P., & Matsumoto, R. R. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(02)00017-9 · Cited by 152
c-Fos Facilitates the Acquisition and Extinction of Cocaine-Induced Persistent Changes
Zhang, J., Zhang, L., Jiao, H., Zhang, Q., Zhang, D., Lou, D., Katz, J. L., & Xu, M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3795-06.2006 · Cited by 152
Effects of Dopamine D1-like and D2-likeAgonists in Rats that Self-Administer Cocaine
Caine, S. B., Negus, S. S., Mello, N. K., & Bergman, J. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35108-0 · Cited by 151
Amphetamine Blocks Long-Term Synaptic Depression in the Ventral Tegmental Area
Jones, S., Gutlerner, J. L., & Kauer, J. A. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05575.2000 · Cited by 151
Berns, G. S., Brooks, A. M., & Spivak, M. (2014) · Behavioural Processes · doi:10.1016/j.beproc.2014.02.011 · Cited by 150
To use or not to use: an update on licit and illicit ketamine use
Li, J., Kasinather, V. B., Cheung, Zhou, Nurhidayat, Jarlais, D., & Schottenfeld, R. S. (2011) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s15458 · Cited by 150
The DRD2 gene in psychiatric and neurological disorders and its phenotypes
Noble, E. P. (2000) · Pharmacogenomics · doi:10.1517/14622416.1.3.309 · Cited by 150
Sander, T., Harms, H., Podschus, J., Finckh, U., Nickel, B., Rolfs, A., Rommelspacher, H., & Schmidt, L. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00044-3 · Cited by 150
Tzschentke, T., & Schmidt, W. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)83329-3 · Cited by 150
Cyclic AMP-Specific Phosphodiesterase-4 as a Target for the Development of Antidepressant Drugs
Zhang, H. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168092 · Cited by 149
Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure
Roberts, D. C. S., & Andrews, M. (1997) · Psychopharmacology · doi:10.1007/s002130050293 · Cited by 149
Role of acetaldehyde in tobacco smoke addiction
Talhout, R., Opperhuizen, A., & van Amsterdam, J. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.02.013 · Cited by 148
Xu, M., Guo, Y. H., Vorhees, C. V., & Zhang, J. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02258-1 · Cited by 148
Metadata
- Authors
- Koob, G. F.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Koob, George F.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 1992-01
- Volume
- 13
- Issue
- 5
- Pages
- 177-184
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2001865657
- Cited by
- 2,070
- References
- 73
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 12 · 2023: 16 · 2022: 17 · 2021: 28 · 2020: 30 · 2019: 28 · 2018: 46 · 2017: 42 · 2016: 43 · 2015: 37 · 2014: 58 · 2013: 53 · 2012: 53
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Pharmacological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA-08459)
- National Institute on Drug Abuse (DA04043, DA04398, R01DA004398, R01DA004043)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- drugs of abuse, brain reward system, dopamine, opioid system, GABA, nucleus accumbens, ventral tegmental area, ethanol reward, opioid reward, operant responding
- MeSH terms
- Animals, Brain, Humans, Reward, Illicit Drugs, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review